Gastroparesis is a medical condition characterized by delayed gastric emptying without any mechanical obstruction, leading to symptoms such as nausea, vomiting, early satiety, bloating, belching, and upper abdominal pain. Recent reports have highlighted cases of stomach paralysis linked to the use of GLP-1 receptor agonists like Ozempic and Wegovy, medications commonly prescribed for type 2 diabetes and weight loss. Ozempic (semaglutide) works by mimicking the incretin hormone GLP-1, which increases insulin secretion, reduces glucagon secretion, and slows gastric emptying. While slowing gastric emptying helps regulate blood sugar levels and suppress appetite, it can sometimes contribute to or exacerbate gastroparesis symptoms. The syndrome of stomach paralysis can be idiopathic but has been found to occur more frequently in patients with diabetes or those using certain medications. In particular, GLP-1 receptor agonist-induced gastroparesis is becoming an acknowledged adverse effect. Patients may experience worsened nausea, vomiting, and feelings of fullness soon after taking the medication, which can significantly impact quality of life. Diagnosis of gastroparesis involves measuring gastric emptying through specialized tests such as gastric emptying scintigraphy. This confirms delayed solid food emptying with no mechanical blockage. Understanding the etiology is crucial since medication-induced gastroparesis may improve upon discontinuation or adjustment of responsible drugs. Healthcare professionals recommend careful monitoring of patients on Ozempic for gastrointestinal symptoms. Those experiencing persistent or severe symptoms should seek evaluation to rule out gastroparesis. Lifestyle modifications, dietary adjustments (such as smaller, frequent meals low in fat and fiber), and medical treatments targeting motility may be advised. In summary, while Ozempic offers substantial benefits for diabetes management and weight control, awareness of potential gastroparesis or 'stomach paralysis' as a side effect is critical. Patients and clinicians should maintain open communication about symptoms to ensure timely diagnosis and appropriate management of this complex condition.